BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32060405)

  • 1. Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasms.
    DiFilippo EC; Coltro G; Carr RM; Mangaonkar AA; Binder M; Khan SP; Rodriguez V; Gangat N; Wolanskyj A; Pruthi RK; Chen D; He R; Viswanatha DS; Lasho T; Finke C; Tefferi A; Pardanani A; Patnaik MM
    Leukemia; 2020 Sep; 34(9):2519-2524. PubMed ID: 32060405
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics.
    Ismael O; Shimada A; Hama A; Elshazley M; Muramatsu H; Goto A; Sakaguchi H; Tanaka M; Takahashi Y; Yinyan X; Fukuda M; Miyajima Y; Yamashita Y; Horibe K; Hanada R; Ito M; Kojima S
    Br J Haematol; 2012 Jul; 158(1):129-37. PubMed ID: 22571758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.
    Karantanos T; Tsai HL; Gondek LP; DeZern AE; Ghiaur G; Dalton WB; Gojo I; Prince GT; Webster J; Ambinder A; Smith BD; Levis MJ; Varadhan R; Jones RJ; Jain T
    Leuk Lymphoma; 2022 Aug; 63(8):1942-1948. PubMed ID: 35379077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Morphology Associated With Germline
    Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
    Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
    Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
    Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
    Yokota A; Huo L; Lan F; Wu J; Huang G
    Mol Cells; 2020 Feb; 43(2):145-152. PubMed ID: 31964134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
    Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
    Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic aberrations in myelodysplastic syndromes and related disorders].
    Makishima H
    Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
    Harada Y; Harada H
    J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations.
    Lachowiez C; Bannon S; Loghavi S; Wang F; Kanagal-Shamanna R; Mehta R; Daver N; Borthakur G; Pemmaraju N; Ravandi F; Patel KP; Garcia-Manero G; Takahashi K; Kantarjian H; Bhalla K; DiNardo CD
    Am J Hematol; 2020 Nov; 95(11):E313-E315. PubMed ID: 32804409
    [No Abstract]   [Full Text] [Related]  

  • 12. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
    Ripperger T; Steinemann D; Göhring G; Finke J; Niemeyer CM; Strahm B; Schlegelberger B
    Leukemia; 2009 Jul; 23(7):1364-6. PubMed ID: 19387465
    [No Abstract]   [Full Text] [Related]  

  • 14. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
    Chen CY; Lin LI; Tang JL; Ko BS; Tsay W; Chou WC; Yao M; Wu SJ; Tseng MH; Tien HF
    Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
    Osato M; Nambu A
    Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
    Hyde RK; Liu P; Friedman AD
    Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.
    Thota S; Gerds AT
    Leuk Lymphoma; 2018 Apr; 59(4):803-812. PubMed ID: 28771058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.
    Tawana K; Wang J; Király PA; Kállay K; Benyó G; Zombori M; Csomor J; Al Seraihi A; Rio-Machin A; Matolcsy A; Chelala C; Cavenagh J; Fitzgibbon J; Bödör C
    Eur J Hum Genet; 2017 Aug; 25(8):1020-1024. PubMed ID: 28513614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
    Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel germline
    Rajpal S; Jain A; Jamwal M; Jain N; Sachdeva MUS; Malhotra P; Varma N; Das R
    Leuk Lymphoma; 2019 Oct; 60(10):2568-2571. PubMed ID: 30990344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.